Hypersensitivity syndrome associated with zalcitabine therapy
- 1 April 1996
- journal article
- Published by Elsevier in The Lancet
- Vol. 347 (9006) , 971
- https://doi.org/10.1016/s0140-6736(96)91459-2
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Combination and Monotherapy with Zidovudine and Zalcitabine in Patients with Advanced HIV DiseaseAnnals of Internal Medicine, 1995
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Dermatologic complications associated with administration of 2′,3′-dideoxycytidine in patients with human immunodeficiency virus infectionJournal of the American Academy of Dermatology, 1989
- PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)The Lancet, 1988